Main > PNEUMOLOGY > Asthma > Treatment > Steroids > Mometasone Furoate. > NonGeneric Mometasone Furoate > Patent. > Claims > Claim 1: CorticoSteroid-Responsive > Disease of Lower Airway Passages > or Lungs. Adm Surfaces Passages > or Lungs by Inhalation from > Dry Powder Inhaler of Aerosolized > Particles of Drug: 25-1000 .mu.g/ > Day of Mometasone Furoate. Claim 3: > Oral Inhalation. Claim 4: Excipient

---

Oral Inhalation. Claim 4: Excipient's subsections
Claim 5: Lactose. Claims 6,7,9:

Oral Inhalation. Claim 4: Excipient's products
This section has no products